Aurinia Pharmaceuticals Inc Cash Flow Quality Index
Aurinia Pharmaceuticals Inc cash flow quality index. Aurinia Pharmaceuticals Inc (AUPH) has a Cash Flow Quality Index of 1.39x as of June 2026. Operating cash flow of $52.17 Million exceeds net income of $37.41 Million, indicating high earnings quality where cash backs reported profits. See Aurinia Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Aurinia Pharmaceuticals Inc (2024–2025)
Cash flow quality index of Aurinia Pharmaceuticals Inc from 2024 to 2025. Historical Cash Flow Quality Index for Aurinia Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Aurinia Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Aurinia Pharmaceuticals Inc Cash Flow Quality Index by Year (2024–2025)
Aurinia Pharmaceuticals Inc cash flow quality index by year from 2024 to 2025. Year-by-year earnings quality comparison for Aurinia Pharmaceuticals Inc. For the full cash flow conversion analysis, see Aurinia Pharmaceuticals Inc cash conversion from operations.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.47x | $135.66 Million | $287.20 Million | ▼ -93.9% |
| 2024 | 7.72x | $44.39 Million | $5.75 Million | — |